Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
Pro-cannabis businesses have accused the U.S. Drug Enforcement Administration of “an unalterably closed mind” toward lowering marijuana to a less-dangerous category level and said the federal agency should be removed from the effort.
Cannabis advocates said the DEA is choosing to include anti-cannabis groups in upcoming hearings on reclassifying cannabis to Schedule III from Schedule I of the Controlled Substance Act and excluding some pro-cannabis perspectives and state agencies from Colorado, which has had legal adult-use cannabis for a decade.
Read the full article at MarketWatch
